An epidemiological reappraisal of the familial aggregation of prostate cancer: A meta-analysis

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Kiciński, Michał ^a   Vangronsveld, Jaco ^a   Nawrot, Tim S ^a,b  

^a HASSELT UNIVERSITY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CAUCASIAN; CONTROLLED STUDY; FAMILIAL CANCER; FAMILY HISTORY; GENE CLUSTER; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; ONSET AGE; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; RELATIVE; RISK FACTOR; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; ANAMNESIS; BELGIUM; CASE CONTROL STUDY; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; PROSTATE TUMOR;

AGED; BELGIUM; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MEDICAL HISTORY TAKING; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84857664026     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027130     Document Type: Article

References (90)

1. Damber JE, Aus G, (2008) Prostate cancer. Lancet 371: 1710-21.
2. Noe M, Schroy P, Marie-France D, Babayan R, Geller A, (2007) Increased cancer risk for individuals with a family history of prostate cancer, colorectal cancer, and melanoma and their associated screening recommendations and practices. Cancer Causes and Control 19: 1-12.
3. Bruner DB, Moore D, Parlanti A, Dorgan J, Engstrom P, (2003) Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int J Cancer 107: 797-803.
4. Johns LE, Houlston RS, (2003) A systematic review and meta-analysis of familial prostate cancer risk. BJU International 91: 789-794.
5. Zeegers MPA, Jellema A, Ostrer H, (2003) Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma. A meta-analysis. Cancer 97: 1894-1903.
6. Brandt A, Bermejo JL, Sundquist J, Hemminki K, (2010) Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members. European Urology 58: 275-280.
7. Kerber RA, O'Brien EO, (2005) A cohort study of cancer risk in relation to family histories of cancer in the Utah population database. Cancer 103: 1906-1915.
8. Isaacs SD, Kiemeney L, Baffoe-Bonnie A, Beaty TH, Walsh PC, (2005) Risk of cancer in relatives of prostate cancer probands. J Natl Cancer Inst 87: 991-996.
9. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC, (1990) Family history and the risk of prostate cancer. The prostate 17: 337-347.
10. Ahn J, Moslehi R, Weinstein J, Snyder K, Virtamo J, et al. (2008) Family history of prostate cancer and prostate cancer risk in the alpha-tocopherol, beta-carotene caner preventions (ATBC) study. Int. J Cancer 123: 1154-1159.
11. Aprikian AG, Bazinet M, Plante M, Meshref A, Trudel C, et al. (1995) Family history and the risk of prostatatic carcinoma in a high risk group of urological patients. The journal of urology 154: 404-406.
12. Hernandez DJ, Han M, Humphreys EB, Mangold LA, Taneja SS, et al. (2008) Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator and prostate-speciic antigen level alone. BJU International 103: 609-614.
13. Mäkinen T, Tammela TL, Stenman U, Määttänen L, Rannikko S, et al. (2002) Family history and prostate cancer screening with prostate-specific antigen. J Clin Oncol 20: 2658-2663.
14. Nam RK, Toi A, Laurence HK, Trachtenberg J, Jewett MA, et al. (2007) Assessing individual risk for prostate cancer. J Clin Oncol 25: 3582-3588.
15. Monroe KR, Mimi CY, Kolonel LN, Coetzee GA, Wilkens LR, et al. (1995) Evidence of an X-linked recessive genetic component to prostate cancer risk. Nature Medicine 1: 827-829.
16. Narod SA, Dupont A, Cusan L, Diamond P, Gomez J, et al. (1995) The impact of family history on early detection of prostate cancer. Nature medicine 1: 99-101.
17. Roemeling S, Monique JR, Vries SH, Gosselaar C, Van der Kwast TH, et al. (2006) Prevalence, treatment modalities and prognosis of familial prostate cancer in a screened population. The Journal of Urology 175: 1332-1336.
18. Ghadirian P, Cadotte M, Lacroix A, Perret C, (1991) Family aggregation of cancer of the prostate in Quebec: The tip of the Iceberg. The prostate 19: 43-52.
19. Multigner L, Ndong JR, Giusti A, Romana M, Delacroix-Maillard H, (2010) Exposure and Risk of Prostate Cancer. J Clin Oncol 28: 3457-3462.
20. Rennert H, Zeigler-Johnson CM, Addya K, Finley MJ, Walker AH, et al. (2005) Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African men. Cancer Epidemiol Biomarkers Prev 14: 949-957.
21. Bai Y, Gao Y, Deng J, Sesterhenn IA, Fraumeni JF, et al. (2005) Risk of prostate cancer and family history of cancer: a population based study in China. Prostate Cancer and Prostatic Diseases 8: 60-65.
22. McCahy PJ, Harris PJ, Neal DE, (1996) Breast and prostate cancer in the relatives of men with prostate cancer. Br J Urol 78: 552-556.
23. Cunningham GR, Ashton CM, Annegers JF, Souchek J, Klima M, et al. (2003) Familial aggregation of prostate cancer in African-Americans and white Americans. The Prostate 56: 256-262.
24. Eldon BJ, Jonsson E, Tomasson J, Tryggvadottir L, Tulinius H, (2003) Familial risk of prostate cancer in Iceland. BJU International 92: 915-919.
25. Matikainen MP, Pukkala E, Schleutker J, Tammela TL, Kovisto P, et al. (2001) Relatives of prostate cancer patients have an increased risk of prostate and stomach cancers: a population-based, cancer registry study in Finland. Cancer Causes and Control 12: 223-230.
26. Keetch DW, Rice JP, Suarez BK, Catalona WJ, (1995) Familial aspects of prostate cancer: a case control study. The Journal of Urology 154: 2100-2102.
27. Verhage BA, Aben KK, Witjes JA, Straatman H, Schalken JA, et al. (2004) Site-specific familial aggregation of prostatic cancer. Int. J Cancer 109: 611-617.
28. Lightfoor N, Conlon M, Kreiger N, Sass-Kortsak A, Purdham J, et al. (2004) Medical history, sexual, and maturational factors and prostate cancer risk. Ann Epidemiol 14: 655-662.
29. Chen Y, Pu YS, Wu H, Wu T, Lai MK, et al. (2009) Cadmium burden and the risk and phenotype of prostate cancer. BMC Cancer 9: 429.
30. Negri E, Pelucchi C, Talamini R, Montella M, Gallus S, et al. (2005) Family history of cancer and the risk of prostate cancer and benign prostatic hyperplasia. Int. J Cancer 114: 648-652.
31. Gallus S, Roberto F, Foschi R, Talamini R, Altieri A, et al. (2007) Risk factors for prostate cancer in men aged less than 60 years: a case-control study from Italy. Urology 70: 1121-1126.
32. Randi G, Pelucchi C, Negri E, Talamini R, Galeone C, et al. (2007) Family history of urogenital cancers in patients with bladder renal cell and prostate cancers. Int. J Cancer 121: 2748-2752.
33. Krain LS, (1974) Some epidemiologic variables in prostatic carcinoma in California. Preventive Medicine 3: 154-159.
34. Krain LS, (1973) Epidemiologic variables in prostatic cancer. Incidence rates on prostatic cancer relate to veneral disease, coital frequency, number of sexual partners, and use of contraceptives. Geriatrics pp. 93-98.
35. Kristoffersson U, Lundgren R, Olsson H, (1997) The risk of malignant tumors in first-degree relatives of men with early onset prostate cancer: a population-based cohort study. European Journal of Cancer 33: 2237-2240.
36. Damber L, Grönberg H, Damber J, (1998) Familial prostate cancer and possible associated malignancies: nation-wide register cohort study in Sweden. Int. J Cancer 78: 293-297.
37. Grönberg H, Damber L, Damber JE, (1996) Familial prostate cancer in Sweden. A nationwide register cohort study. Cancer 77: 138-143.
38. Grönberg H, Wiklund F, Damber JE, (1999) Age specific risks of familial prostate carcinoma. A basis for screening recommendations in high risk populations. Cancer 86: 477-483.
39. Hemminki K, Dong C, (2000) Familial prostate cancer from the family-cancer database. European Journal of Cancer 36: 229-234.
40. Hemminki K, Li X, Plna K, Granström C, Vaittinen P, (2001) The nation-wide Swedish family-cancer database. Acta Oncologica 40: 772-777.
41. Hemminki K, Czene K, (2002) Attributable risks of familial cancer from the family-cancer database. Cancer Epidemiol Biomarkers Prev 11: 1638-1644.
42. Hemminki K, Li X, Czene K, (2002) Age specific and attributable risks of familial prostate carcinoma from the maily-cancer database. Cancer 15: 346-353.
43. Hemminki K, Li X, Czene K, (2003) Familial risk of cancer: data for clinical counseling and cancer genetics. Int. J Cancer 108: 109-114.
44. Hemminki K, Sundquist J, Bermejo JL, (2008) How common is familial cancer? Annals of Oncology 19: 163-167.
45. Ji J, Eng C, Hemminki K, (2008) Familial risk for soft tissue tumors: a nation-wide epidemiological study from Sweden. J Cancer Res Clin Oncol 134: 617-624.
46. Cannon L, Bishop DT, Skolnick M, Hunt S, Lyon JL, et al. (1982) Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surveys 1: 47-69.
47. Goldgar DE, Douglas FE, Cannon-Albright LA, Skolnick MH, (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. Journal of the National Cancer Institute 86: 1600-1608.
48. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC, (2007) Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int. J Cancer 121: 1571-1578.
49. Chen Y, Page JH, Chen R, Giovannucci E, (2008) Family history of prostate and breast cancer and the risk of prostate cancer in the PSA Era. The Prostate 68: 1582-1591.
50. Andersson S, Baron J, Bergström R, Lindgren C, Wolk A, et al. (1996) Lifestyle factors and prostate cancer risk: a case-control study in Sweden. Cancer Epidemiol Biomarkers Prev 5: 509-513.
51. Bratt O, Kristoffersson U, Lundgren R, Olsson H, (1999) Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study. European Journal of Cancer 35: 271-277.
52. Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, et al. (2008) Cumulative association of five genetic variants with prostate cancer. N Engl J Med 358: 910-919.
53. Zheng SL, Sun J, Wiklund F, Gao Z, Stattin P, et al. (2009) Genetic variants and family history predict prostate cancer similar to prostate-specific antigen. Clin Cancer Res 15: 1105-1111.
54. West DW, Slattery ML, Robison LM, French TK, Mahoney AW, (1991) Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer causes and control 2: 85-94.
55. Beebe-Dimmer JL, Drake EA, Dunn RL, Bock CH, Montie JE, et al. (2006) Association between family history of prostate and breast cancer among African-American men with prostate cancer. Urology 68: 1072-1076.
56. Fincham SM, Hill GB, Hanson J, Wijayasinghe C, (1990) Epidemiology of prostate cancer. The Prostate 17: 189-206.
57. Ghadirian P, Howe GR, Hislop TG, Maisonneuve P, (1997) Family history of prostate cancer: a multi-center case-control study in Canada. Int. J Cancer 70: 679-681.
58. Glover FE, Coffey DS, Douglas LL, Russel H, Cadigan M, et al. (1998) Familial study of prostate cancer in Jamaica. Urology 52: 441-443.
59. Hayes RB, Lifi JM, Pottern LM, Greenberg RS, Schoenberg JB, et al. (1995) Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int. J Cancer 60: 361-364.
60. Honda GD, Bernstein L, Ross RK, Greenland S, Gerkins V, et al. (1988) Vasectomy, cigarette smoking, and age at first sexual intercourse as risk factors for prostate cancer in middle-aged men. Br. J Cancer 57: 326-331.
61. Justine L, Gina A, Lin F, (2006) Vietnam military service history and prostate cancer. BMC Public Health 6: 75.
62. Kolonel LN, Yoshizawa CN, Hankin JH, (1988) Diet and prostatic cancer: a case-control study in Hawaii. Am J Epidemiol 127: 999-1012.
63. Lesko SM, Rosenberg L, Shapiro S, (1996) Family history and prostace cancer risk. Am J Epidemiol 144: 1041-1047.
64. Magura L, Blanchard R, Hope B, (2008) Hypercholesterolemia and prostate cancer: a hospital-based case-control study. Cancer Causes Control 19: 1259-1266.
65. Mettlin C, Natarajan N, Huben R, Raghavan D, (1995) Reported family history of cancer in 1,271 prostate cancer cases and 1,909 controls. Urol Oncol 1: 240-245.
66. Rovito PM Jr, Morse PD, Spinek K, Newman N, Jones RF, et al. (2005) Heterocyclic amines and genotype of N-acetyltransferases as risk factors for prostate cancer. Prostate cancer and prostatic diseases 8: 69-74.
67. Rybicki BA, Neslund-Dudas C, Nock NL, Schultz LR, Eklund L, et al. (2006) Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with GSTP1 Ile105Val polymorphism. Cancer detection and prevention 30: 412-422.
68. Salinas CA, Koopmeiners JS, Kwon EM, Fitzgerald L, Lin DW, et al. (2009) Clinical utility of five genetic variants for predicting prostate cancer risk and mortality. The prostate 69: 363-372.
69. Schuman LM, Mandel J, Blackard C, Bauer H, Scarlett J, et al. (1977) Epidemiologic study of prostatic cancer: preliminary report. Cancer Treat Rep 61: 181-186.
70. Spitz MR, Currier RD, Fueger JJ, Babaian RJ, Newell GR, (1991) Familial patterns of prostate cancer: a case-control analysis. The Journal of Urology 146: 1305-1307.
71. Staples MP, Giles GG, English DR, McCredie MR, Severi G, et al. (2003) Risk of prostate cancer associated with a family history in an era of rapid increase in prostate cancer diagnosis (Australia). Cancer Causes and Control 14: 161-166.
72. Steele R, Lees RE, Kfarus AS, Rao C, (1971) Sexual factors in the epidemiology of cancer of the prostate. J Chron Dis 24: 29-37.
73. Stone NS, Hoffman RM, Tollestrup K, Stidley AC, Witter JL, et al. (2003) Family history, Hispanic ethnicity, and prostate cancer risk. Ethnicity and disease 13: 233-239.
74. Strom SS, Yamamura Y, Flores-Sandoval FN, Petteway CA, Lopez DS, (2008) Prostate cancer in Mexican-Americans: identification of risk factors. The prostate 68: 563-570.
75. Suzuki T, Matsuo K, Kenji W, Hiraki A, Hiroso K, et al. (2007) Effect of familial history and smoking on common cancer risks in Japan. Cancer 109: 2116-2123.
76. Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, et al. (1995) Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol 141: 732-740.
77. Zhu K, Stanford JL, Daling JR, MCKnight B, Stergachis A, et al. (1996) Vasectomy and prostate cancer: a case-control study in a health maintenance organization. Am J Epidemiol 144: 717-722.
78. Cerhan JR, Parker AS, Putnam SD, Chiu BC, Lynch CF, et al. (1999) Family history and prostate cancer risk in a population-based cohort of Iowa men. Cancer Epidemiol Biomarkers Prev 8: 53-60.
79. Kalish LA, McDougal WS, McKinlay JB, (2000) Family history and the risk of prostate cancer. Urology 56: 803-806.
80. Park SY, Wilkens LR, Henning SM, Marchand LL, Gao K, et al. (2009) Circulating fatty acids and prostate cancer risk in a nested case-control study: the Multiethnic Cohort. Cancer Causes Control 20: 211-223.
81. Schuurman AG, Zeegers MP, Goldbohm A, Van Den Brandt PA, (1999) A case-cohort study on prostate cancer risk in relation to family history of prostate cancer. Epidemiology 10: 192-195.
82. Sun J, Chang B, Isaacs SD, Wiley KE, Wiklund F, et al. (2008) Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations. The Prostate 68: 1257-1262.
83. King G, Zeng L, (2002) Estimating risk and rate levels, ratios and differences in case-control studies. Statistics in medicine 21: 1409-1427.
84. Benichou J, (2007) Biostatistics and epidemiology: measuring the risk attributable to an environmental or genetic factor. C.R. Biologies 330: 281-298.
85. Rothman KJ, Greenland S, eds. (1998) Modern epidemiology. Philadelphia, PA Lippincott-Raven 2nd ed.
86. Nawrot TS, Perez L, Künzli N, Munters E, Nemery B, (2011) Public health importance of triggers of myocardial infarction: a comparative risk assessment. Lancet 377: 732-740.
87. Benichou J, (2001) A review of adjusted estimators of attributable risk. Statistical Methods in Medical Research 10: 195-216.
88. Greenland S, (2001) Estimation of population attributable fractions from fitted incidence ratios and exposure survey data, with an application to electromagnetic fields and childhood leukemia. Biometrics 57: 182-188.
89. Greenland S, (2004) Interval estimation by simulation as an alternative to and extension of confidence intervals. International Journal of Epidemiology 33: 1389-1397.
90. Egger M, Smith GD, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.